Integrative Molecular Phenotyping
INTEGRATIVE MOLECULAR
PHENOTYPING
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY

Error message

Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in menu_set_active_trail() (line 2396 of /customers/3/9/7/metabolomics.se/httpd.www/includes/menu.inc).

Evangelia Daskalaki

Evangelia Daskalaki obtained her PhD in Metabolomics from the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS) of the University of Strathclyde (UK, 2015). She received a scholarship from the World Anti-Doping Agency and SIPBS to investigate the use of a LC-MS based approach to detect a metabolic signature of recombinant human erythropoietin (r-HuEPO) in various biological matrices of Caucasian endurance trained men, under the supervision of Dr David Watson. During her first post-doctoral position at the same university (2015-2016), Evangelia was seconded to the London College of Fashion (UK) to develop cosmetics with specialized actives of bee venom, with the aim to commercialize the research output to further pharmaceutical interests in these actives. The work was funded by the Impact Acceleration Account (University of Strathclyde) via the Engineering and Physical Sciences Research Council (EPSRC). In March 2017, Evangelia joined the Wheelock Lab to investigate the role of small molecule metabolites in immuno-metabolism, in a collaborative set of projects funded by the Novo Nordisk Foundation (NNF).